Riskpilot← Back to searchSign inGet full accessCB Diagnostics AB
ABActiveOrg 5567129316Rapsgatan 7 PActivities of holding companies · NACE 6421Est. 20060 employees
Revenue 2024
SEK 0
EBITDA margin
—
-595% vs 2023
Equity ratio
12.7%
Financial strength
Net profit 2024
SEK -205,9M
+20% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -827K | -595% |
| Net profit | SEK -205,9M | +20% |
| Total assets | SEK 9,6B | +1% |
| Equity | SEK 1,2B | -15% |
| Employees | 0 | — |
Legal name
CB Diagnostics AB
Org number
5567129316
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
14 oktober 2006
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, aktivt verka för en ändamålsenlig samordning och utveckling av den verksamhet som bedrivs i dotterbolag, främst avseende utveckling, tillverkning och marknadsföring av diagnostiska produkter samt därmed förenlig verksamhet.
Address
Rapsgatan 7 P
Phone
+4618165000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 707 | −584 | −360 | 1 655 | 0 | −755 | 740 | −97 | 167 | −827 |
| Depreciation & amort. | −0 | −0 | — | −0 | — | −0 | −0 | −0 | −0 | −0 |
| EBIT | 707 | −584 | −360 | 1 655 | 0 | −755 | 740 | −97 | 167 | −827 |
| Net financials | −203 681 | −203 672 | −186 699 | −203 672 | — | −203 699 | −203 699 | −203 730 | −256 927 | −341 029 |
| Profit before tax | −202 973 | 316 354 | −187 059 | −202 017 | 0 | −204 454 | −202 957 | −203 827 | −256 760 | −182 429 |
| Tax | 45 817 | −68 321 | 19 033 | 42 828 | — | 151 | 1 395 | 505 | 614 | −23 453 |
| Net profit | −157 156 | 248 033 | −168 026 | −159 189 | — | −204 303 | −201 562 | −203 322 | −256 146 | −205 882 |
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 936 499 | 9 384 228 | 9 399 895 | 9 437 361 | — | 9 434 224 | 9 432 891 | 9 424 333 | 9 423 338 | 9 559 404 |
| Equity | 3 080 064 | 2 628 097 | 2 460 068 | 2 300 871 | — | 2 079 853 | 1 878 290 | 1 674 990 | 1 418 844 | 1 212 962 |
| Long-term debt | 3 133 415 | 3 133 415 | 3 133 415 | 3 133 415 | — | 3 133 415 | 3 133 415 | 3 133 415 | 3 133 415 | 3 133 415 |
| Short-term debt | 2 687 780 | 3 592 037 | 3 779 917 | 3 981 387 | — | 4 202 942 | 4 405 471 | 4 602 546 | 4 860 179 | 5 202 127 |
| Total debt | 5 821 195 | 6 725 452 | 6 913 332 | 7 114 802 | — | 7 336 357 | 7 538 886 | 7 735 961 | 7 993 594 | 8 335 542 |
EBITDA margin
-82700000.0%
This company
15.8%
Market median
-523417822% vs market
20162024
Equity ratio
12.7%
This company
38.2%
Market median
-67% vs market
20162024
Return on equity
-17.0%
This company
18.4%
Market median
-192% vs market
20162024
Net profit margin
-20588200000.0%
This company
8.1%
Market median
-254175308742% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
6.88×
This company
0.62×
Market median
-1010% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-12-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Chief Auditor | Chief Auditor | 2023 | — | — |
HC Authorized Recipient of Service | Authorized Recipient of Service | 2020 | — | — |
LG Chief Auditor | Chief Auditor | 2020 | — | — |
VG Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
EE Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CB Diagnostics Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Perbio Science ABPerbio Science Sweden Holdings ABCB Diagnostics Holding AB
CB Diagnostics AB (this company)Beijing Phadia Diagnostics Co., LtdPhadia Us Inc.Phadia Us IncLaboratory Specialities (Ptd) LtdBeijing Phadia Diagnostics Co LtdPhadia India Private LimitedPhadia Diagn¢sticos LtdaPHADIA INDIA PRIVATE LIMITEDBEIJING PHADIA DIAGNOSTICS CO., LTDLABORATORY SPECIALITIES (PTD) LTDPHADIA US INC.PHADIA DIAGN¢STICOS LTDABoard members of CB Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Maria Josefine Jernebring | Chief Auditor | 0 companies |
| Hanna Chainikova | Authorized Recipient of Service | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Valerio Gaddi | Authorized Recipient of Service | 0 companies |
| Elias Ego | Authorized Recipient of Service | 0 companies |
| Marcel Jacobus van der Meijden | Board of Directors | 0 companies |
| Bram Monster | Board of Directors | 0 companies |
| Anthony Hugh Smith | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |